Q13164 (MK07_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 117.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Mitogen-activated protein kinase 7 Short name=MAP kinase 7 Short name=MAPK 7 EC=2.7.11.24 Alternative name(s): Big MAP kinase 1 Short name=BMK-1 Extracellular signal-regulated kinase 5 Short name=ERK-5 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 816 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Ref.8 Ref.9 Ref.10 Ref.11 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Cofactor | Magnesium By similarity. |
| Enzyme regulation | Activated by tyrosine and threonine phosphorylation By similarity. Activated in response to hyperosmolarity, hydrogen peroxide, and epidermal growth factor (EGF). Ref.8 Ref.9 |
| Subunit structure | Interacts with MAP2K5. Forms oligomers By similarity. Interacts with MEF2A, MEF2C and MEF2D; the interaction phosphorylates the MEF2s and enhances transcriptional activity of MEF2A, MEF2C but not MEF2D By similarity. Interacts with SGK1. Ref.2 Ref.10 |
| Subcellular location | Cytoplasm. Nucleus. Note: Translocates to the nucleus upon activation. Ref.8 |
| Tissue specificity | Expressed in many adult tissues. Abundant in heart, placenta, lung, kidney and skeletal muscle. Not detectable in liver. Ref.2 |
| Domain | The second proline-rich region may interact with actin targeting the kinase to a specific location in the cell. The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases. |
| Post-translational modification | Dually phosphorylated on Thr-219 and Tyr-221, which activates the enzyme By similarity. Autophosphorylated in vitro on threonine and tyrosine residues when the C-terminal part of the kinase, which could have a regulatory role, is absent. Ref.12 Ref.13 Ref.14 |
| Sequence similarities | Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily. Contains 1 protein kinase domain. |
| Sequence caution | The sequence AAA81381.1 differs from that shown. Reason: Frameshift at positions 19 and 32. The sequence BAD92848.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| MAP2K5 | Q13163 | 2 | EBI-1213983,EBI-307294 | |
| PML | P29590 | 6 | EBI-1213983,EBI-295890 |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q13164-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q13164-2) The sequence of this isoform differs from the canonical sequence as follows: 1-139: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q13164-3) The sequence of this isoform differs from the canonical sequence as follows: 493-816: DGPSAPLEAP...LADLPDLQDP → GALWAGRVGR...KWPQRTPGGS | ||||||
| Isoform 4 (identifier: Q13164-4) The sequence of this isoform differs from the canonical sequence as follows: 1-133: MAEPLKEEDG...TVPYGEFKSV → MLFFHTMPSA...HASLLPSPSS 493-816: DGPSAPLEAP...LADLPDLQDP → GALWAGRVGR...KWPQRTPGGS | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.7 | ||||||
| Chain | 2 – 816 | 815 | Mitogen-activated protein kinase 7 | PRO_0000186260 | |||||
Regions | |||||||||
| Domain | 55 – 347 | 293 | Protein kinase | ||||||
| Nucleotide binding | 61 – 69 | 9 | ATP By similarity | ||||||
| Region | 2 – 77 | 76 | Required for cytoplasmic targeting By similarity | ||||||
| Region | 78 – 139 | 62 | Required for binding to MAP2K5 By similarity | ||||||
| Region | 140 – 406 | 267 | Necessary for oligomerization By similarity | ||||||
| Region | 407 – 806 | 400 | May not be required for kinase activity; required to stimulate MEF2C activity By similarity | ||||||
| Region | 505 – 539 | 35 | Nuclear localization signal By similarity | ||||||
| Motif | 219 – 221 | 3 | TXY | ||||||
| Compositional bias | 338 – 341 | 4 | Poly-Ala | ||||||
| Compositional bias | 403 – 694 | 292 | Pro-rich | ||||||
| Compositional bias | 513 – 543 | 31 | Arg-rich | ||||||
Sites | |||||||||
| Active site | 182 | 1 | Proton acceptor By similarity | ||||||
| Binding site | 84 | 1 | ATP By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.7 | ||||||
| Modified residue | 219 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 221 | 1 | Phosphotyrosine Ref.12 Ref.14 | ||||||
| Modified residue | 720 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 731 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 733 | 1 | Phosphothreonine Ref.13 Ref.14 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 139 | 139 | Missing in isoform 2. | VSP_035198 | |||||
| Alternative sequence | 1 – 133 | 133 | MAEPL…EFKSV → MLFFHTMPSAPMGSQGKAVT CLESEGCGEDGACPWSVIRP THASLLPSPSS in isoform 4. | VSP_035199 | |||||
| Alternative sequence | 493 – 816 | 324 | DGPSA…DLQDP → GALWAGRVGRGETWTWTRLQ AFTFSPAQLPRKWPQRTPGG S in isoform 3 and isoform 4. | VSP_035200 | |||||
| Natural variant | 535 | 1 | R → H. Ref.15 | VAR_046225 | |||||
| Natural variant | 550 | 1 | G → A. Ref.15 Corresponds to variant rs56388327 [ dbSNP | Ensembl ]. | VAR_042257 | |||||
Experimental info | |||||||||
| Mutagenesis | 219 – 221 | 3 | TEY → AEF: Loss activation by MAP2K5. Ref.8 | ||||||
| Sequence conflict | 610 | 1 | V → L in AAA81381. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Primary structure of BMK1: a new mammalian map kinase." Lee J.-D., Ulevitch R.J., Han J. Biochem. Biophys. Res. Commun. 213:715-724(1995) [PubMed: 7646528] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. Tissue: Placenta. |
| [2] | "Components of a new human protein kinase signal transduction pathway." Zhou G., Bao Z.Q., Dixon J.E. J. Biol. Chem. 270:12665-12669(1995) [PubMed: 7759517] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH MAP2K5, TISSUE SPECIFICITY. Tissue: Fetal brain. |
| [3] | "Identification and characterization of mErk5-T, a novel Erk5/Bmk1 splice variant." McCaw B.J., Chow S.Y., Wong E.S.M., Tan K.L., Guo H., Guy G.R. Gene 345:183-190(2005) [PubMed: 15716121] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). Tissue: Placenta. |
| [4] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Spleen. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Muscle and Pancreas. |
| [7] | Bienvenut W.V., Fleming J., Leug H.Y. Submitted (JAN-2010) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-35; 75-98; 119-131; 198-205; 296-343; 377-392; 468-485; 489-505; 544-571; 720-735 AND 798-816, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, MASS SPECTROMETRY. Tissue: Hepatoma. |
| [8] | "BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C." Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., Lee J.-D. EMBO J. 16:7054-7066(1997) [PubMed: 9384584] [Abstract] Cited for: FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, MUTAGENESIS OF 219-THR--TYR-221. |
| [9] | "Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor." Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., Lee J.-D. Nature 395:713-716(1998) [PubMed: 9790194] [Abstract] Cited for: FUNCTION, ENZYME REGULATION. |
| [10] | "BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase." Hayashi M., Tapping R.I., Chao T.H., Lo J.F., King C.C., Yang Y., Lee J.D. J. Biol. Chem. 276:8631-8634(2001) [PubMed: 11254654] [Abstract] Cited for: FUNCTION, INTERACTION WITH SGK1. |
| [11] | "Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival." Dong F., Gutkind J.S., Larner A.C. J. Biol. Chem. 276:10811-10816(2001) [PubMed: 11278431] [Abstract] Cited for: FUNCTION. |
| [12] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-221, MASS SPECTROMETRY. Tissue: Lung carcinoma. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-720 AND THR-733, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-221; SER-731 AND THR-733, MASS SPECTROMETRY. |
| [15] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed: 17344846] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] HIS-535 AND ALA-550. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U29725 mRNA. Translation: AAA82931.1. U29726 mRNA. Translation: AAA82932.1. U29727 Genomic DNA. Translation: AAA82933.1. U25278 mRNA. Translation: AAA81381.1. Frameshift. AY534741 mRNA. Translation: AAS38577.1. AB209611 mRNA. Translation: BAD92848.1. Different initiation. CH471212 Genomic DNA. Translation: EAW50883.1. CH471212 Genomic DNA. Translation: EAW50886.1. BC007404 mRNA. Translation: AAH07404.1. BC007992 mRNA. Translation: AAH07992.1. BC009963 mRNA. Translation: AAH09963.1. BC030134 mRNA. Translation: AAH30134.1. |
| IPI | IPI00149048. IPI00219601. IPI00426283. IPI00555640. |
| PIR | B56708. |
| RefSeq | NP_002740.2. NM_002749.3. NP_620601.1. NM_139032.2. NP_620602.2. NM_139033.2. NP_620603.2. NM_139034.2. |
| UniGene | Hs.150136. |
3D structure databases | |
| ProteinModelPortal | Q13164. |
| SMR | Q13164. Positions 48-387. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q13164. 15 interactions. |
| STRING | Q13164. |
PTM databases | |
| PhosphoSite | Q13164. |
Polymorphism databases | |
| DMDM | 205371766. |
Proteomic databases | |
| PRIDE | Q13164. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000308406; ENSP00000311005; ENSG00000166484. ENST00000395602; ENSP00000378966; ENSG00000166484. ENST00000395604; ENSP00000378968; ENSG00000166484. |
| GeneID | 5598. |
| KEGG | hsa:5598. |
Organism-specific databases | |
| CTD | 5598. |
| GeneCards | GC17P019221. |
| HGNC | HGNC:6880. MAPK7. |
| HPA | CAB018561. |
| MIM | 602521. gene. |
| neXtProt | NX_Q13164. |
| PharmGKB | PA30625. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG04009. |
| GeneTree | ENSGT00550000074298. |
| HOVERGEN | HBG108137. |
| InParanoid | Q13164. |
| OMA | SMSESPD. |
| OrthoDB | EOG4H463D. |
| PhylomeDB | Q13164. |
Enzyme and pathway databases | |
| BRENDA | 2.7.11.24. 2681. |
| Pathway_Interaction_DB | mapktrkpathway. Trk receptor signaling mediated by the MAPK pathway. |
| Reactome | REACT_111102. Signal Transduction. REACT_6900. Immune System. |
Gene expression databases | |
| ArrayExpress | Q13164. |
| Bgee | Q13164. |
| CleanEx | HS_MAPK7. |
| Genevestigator | Q13164. |
| GermOnline | ENSG00000166484. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR011009. Kinase-like_dom. IPR003527. MAP_kinase_CS. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR017442. Se/Thr_kinase-like_dom. IPR008271. Ser/Thr_kinase_AS. IPR002290. Ser/Thr_kinase_dom. [Graphical view] |
| KO | K04464. |
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] |
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS01351. MAPK. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 21728. |
| SOURCE | Search... |
Entry information
| Entry name | MK07_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13164 Secondary accession number(s): Q16634 Q96G51 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with